Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2024 Earnings Call Transcript

Joe Sardano: It’s a very frustrating time right now for us to be working with the FDA, and I sympathize with the amount of work and the bottlenecks that they’ve had. And so it’s a tough position with TDI. They have a bunch of people that are trying to get things done, but there’s such a backlog, it’s tough for us to even get a phone call returned. So we keep persisting. We’re on track. We’re not getting any questions back. Any questions that we did have, we already answered. And so we’re in a wait-and-hold position until that happens. We’re disappointed that it hasn’t happened, but we expect it to happen.

Anthony Vendetti: Thanks very much. I’ll hop back into the queue. Appreciate the call.

Joe Sardano: Thanks, Anthony.

Operator: [Operator Instructions] This concludes our question-and-answer session. I would like to turn the conference back over to Joe Sardano for any closing remarks.

Joe Sardano: Thank you, everyone, for being on the call. And thank you once again for your time this afternoon and for your interest in Sensus Healthcare. We plan to conduct virtual one-on-one meetings with the investment community in the coming weeks. Please contact LHA, our investor relations firm, if you’d like to request a meeting. We’ll speak with you again when we report second quarter financial results in August. In the meantime, thank you again for joining us and Happy Mother’s Day.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.